专利检索 ap:("Aventis Pharma S.A.") AND inv:"Henin" 第 1 页

1.

发明申请
Combination of a CB1 receptor antagonist and of a product which activatives dopaminergic neurotransmission in the brain, the pharmaceutical compositions comprising them and their use in the treatment of parkinson's disease 失效
标题翻译： CB1受体拮抗剂与大脑中多巴胺能神经传递活性物质的组合，包含它们的药物组合物及其在治疗帕金森病中的应用

公开(公告)号：US20040209861A1

公开(公告)日：2004-10-21

申请号：US10786810

申请日：2004-02-25

申请人： Aventis Pharma S.A.

发明人： Jesus Benavides , Daniel Boccio , Yvette Henin , Odile Piot-Grosjean , Henin

IPC分类号： A61K031/397 , A61K031/445 , A61K031/4015

CPC分类号： A61K9/4858 , A61K31/397 , A61K31/4353 , A61K45/06 , A61K2300/00

摘要： The present invention relates to the combination of one or more CB1 antagonist azetidine derivatives and of one or more products which activate dopaminergic neurotransmission in the brain, to the pharmaceutical compositions comprising them and to their use in the treatment of Parkinson's disease.

摘要翻译： 本发明涉及一种或多种CB1拮抗剂氮杂环丁烷衍生物和一种或多种在脑中激活多巴胺能神经传递的产物与包含它们的药物组合物及其在治疗帕金森病中的用途的组合。